Susan M. Domchek
- Oncology top 0.05%
- Genetics top 0.05%
- Molecular Biology top 1%
- Cancer Research top 0.1%
- Pulmonary and Respiratory Medicine top 0.5%
- Co-authors
- Mark E. RobsonNadine TungJudy E. GarberKatherine L. NathansonElżbieta SenkusNorikazu MasudaAnne ArmstrongBinghe Xu
- Topics
- BRCA gene mutations in cancer (204 papers)PARP inhibition in cancer therapy (81 papers)Cancer Genomics and Diagnostics (62 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Susan M. Domchek
315 papers receiving 19.3k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 10.2k
- Genetics 8.8k
- Molecular Biology 6.0k
- Cancer Research 4.9k
- Pulmonary and Respiratory Medicine 3.0k
Countries citing papers authored by Susan M. Domchek
This map shows the geographic impact of Susan M. Domchek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Domchek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Domchek more than expected).
Fields of papers citing papers by Susan M. Domchek
This network shows the impact of papers produced by Susan M. Domchek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Domchek. The network helps show where Susan M. Domchek may publish in the future.
Co-authorship network of co-authors of Susan M. Domchek
This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Domchek. A scholar is included among the top collaborators of Susan M. Domchek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Domchek. Susan M. Domchek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 57 | |
| 6 | 35 | |
| 7 | The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer. | 1 |
| 8 | 186 | |
| 9 | Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutationbreakdown → | 2156 |
| 10 | 280 | |
| 11 | 31 | |
| 12 | 89 | |
| 13 | 101 | |
| 14 | 234 | |
| 15 | 14 | |
| 16 | 82 | |
| 17 | 381 | |
| 18 | 128 | |
| 19 | 75 | |
| 20 | 41 |
About Susan M. Domchek
Susan M. Domchek is a scholar working on Genetics, Oncology and Reproductive Medicine, having authored 334 papers that have together received 19.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (204 papers), PARP inhibition in cancer therapy (81 papers) and Cancer Genomics and Diagnostics (62 papers). The work is most often cited by research in Oncology (10.2k citations), Cancer Research (4.9k citations) and Genetics (8.8k citations). Susan M. Domchek has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mark E. Robson, Nadine Tung, Judy E. Garber, Katherine L. Nathanson, Elżbieta Senkus, Norikazu Masuda, Anne Armstrong, Binghe Xu, Pierfranco Conté and Seock‐Ah Im. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.